nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical Universitynefr-234Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESФОТОФЕРЕЗ ПРИ ТРАНСПЛАНТАЦИИ ПОЧЕКPHOTOPHERESIS DURING KIDNEY TRANSPLANTATIONФаенкоА. П.FaenkoA. P.

Фаенко Александр Павлович - Старший лаборант курса клинической трансфузиологии. 129110, Россия, Москва, ул. Щепкина, д. 61/2, корп. 8.  

Alexander P. Faenko, Senior Assistant of the Department of Clinical Transfusion.

Adress: 129110 Russia, Moscow, Shchepkina st., 61/2, build. 8. 

alexfaenko@mail.ruВатазинА. В.VatazinA. V.

Ватазин Андрей Владимирович, доктор медицинских наук, профессор. Руководитель отдела трансплантологии, нефрологии и хирургической гемокоррекции. 129110, Москва, ул. Щепкина, д. 61/2, корп. 6. 

Andrey V. Vatazin, MD, PhD, Professor of medicine, DMedSci. 

Head of the Department of Transplantation, Nephrology and Surgical hemocorrection. 

Adress: 129110, Moscow, Shchepkin Str., 61/2, building 6. 

vatazin@yandex.ruКильдюшевскийА. В.KildjushevskiyA. V.

Кильдюшевский Александр Вадимович, доктор медицинских наук, профессор.Ведущий научный сотрудник отделения хирургической гемокоррекции и детоксикации.129110, Россия, Москва, ул. Щепкина, д. 61/2, корп. 11. 

Alexander V. Kildushevskiy, Prof, MD, PhD, DMedSci.Leading researcher of the department of Surgical hemocorrection and detoxifi cation.Adress: 129110 Russia, Moscow, Shchepkina st., 61/2, build. 11. 

kildushev@yandex.ruФедулкинаВ. А.FedulkinaV. V.

Федулкина Вероника Андреевна, кандидат медицинских наук.

Старший научный сотрудник хирургического отделения трансплантологии и диализа.

129110, Россия, Москва, ул. Щепкина, д. 61/2, корп. 6

Veronica A. Fedulkina MD, PhD,Senior Researcher of the Surgical department of Transplantation and Dialysis. Adress: 129110 Russia, Moscow, Shchepkina st., 61/2, build. 6.  

v.fedulkina@mail.ruМосковский областной научно-исследовательский клинический институт им. М.Ф. ВладимирскогоРоссияMoscow regional research and clinical institute named after M.F. VladimirskyRussian Federation2016030320172064248Copyright © Фаенко А.П., Ватазин А.В., Кильдюшевский А.В., Федулкина В.А., 20172017Фаенко А.П., Ватазин А.В., Кильдюшевский А.В., Федулкина В.А.Faenko A.P., Vatazin A.V., Kildjushevskiy A.V., Fedulkina V.V.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/234

Современная концепция посттрансплантационного введения больных направлена на редукцию иммуносупрессии, при которой отмечается минимальность побочных действий данных препаратов и не возникает отторжение почечного аллотрансплантата. Одним из методов, способствующих снижению риска отторжения и формированию иммунологической толерантности, является фотоферез. В статье представлен обзор литературных данных по применению фотофереза при трансплантациях солидных органов и приведены механизмы его действия.

The modern concept of patient’s post-transplantation care is focused on immunosuppression reduction where minimal side effects of these medications is registered and there is no rejection of renal allograft. Photopheresis is one of methods which inspire decrease of allograft rejection and immunotolerance formation.

экстракорпоральная фотохимиотерапияфотоферезиммунологическая толерантностьотторжение почечного аллотрансплантатаExtracorporeal photochemotherapyphotopheresisimmunotolerancerenal allograft rejectionReferencesЛубенников АЕ, Трушкин РН, Артюхина ЛЮ. Современные взгляды на проблему удаления почечного трансплантата. Московск хирург журн 2014; 4: 49-56 [Lubennikov AE, Trushkin RN, Artyukhina LY Sovremennye vzglyady na problemu udaleniya pochechnogo transplantata. Moskovskii khirurgicheskii zhurnal. 2014; 4: 49-56]Лубенников АЕ, Трушкин РН, Артюхина ЛЮ. Современные взгляды на проблему удаления почечного трансплантата. Московск хирург журн 2014; 4: 49-56 [Lubennikov AE, Trushkin RN, Artyukhina LY Sovremennye vzglyady na problemu udaleniya pochechnogo transplantata. Moskovskii khirurgicheskii zhurnal. 2014; 4: 49-56]Johnston O, Rose C, Landsberg D et al. Nephrectomy after transplant failure: current practice and outcomes. Am J Transplant 2007; 7(8): 1961-1967. doi: 10.1111/j.1600-6143.2007.01884.xJohnston O, Rose C, Landsberg D et al. Nephrectomy after transplant failure: current practice and outcomes. Am J Transplant 2007; 7(8): 1961-1967. doi: 10.1111/j.1600-6143.2007.01884.xZambon JP, Magalhaes RS, Ko I et al. Kidney regeneration: Where we are and future perspectives. World J Nephrol 2014; 3(3): 24-30. doi: 10.5527/wjn.v3.i3.24Zambon JP, Magalhaes RS, Ko I et al. Kidney regeneration: Where we are and future perspectives. World J Nephrol 2014; 3(3): 24-30. doi: 10.5527/wjn.v3.i3.24Yu H, Kim HS, Baek CH et al. Risk Factors for Hypertension After Living Donor Kidney Transplantation in Korea: A Multivariate Analysis. Transplant Proc 2016; 48(1): 88-91. doi: 10.1016/j.transproceed.2015.12.020Yu H, Kim HS, Baek CH et al. Risk Factors for Hypertension After Living Donor Kidney Transplantation in Korea: A Multivariate Analysis. Transplant Proc 2016; 48(1): 88-91. doi: 10.1016/j.transproceed.2015.12.020Peter W, Edelson RL. New Therapies for Cutaneous T-Cell Lymphoma. Arch Dermatol 1987; 123(2): 189-191. doi:10.1001/archderm.1987.01660260059012Peter W, Edelson RL. New Therapies for Cutaneous T-Cell Lymphoma. Arch Dermatol 1987; 123(2): 189-191. doi:10.1001/archderm.1987.01660260059012Otman SG, Edwards C, Pearse AD et al. Modulation of ultraviolet (UV) transmission by emollients: relevance to narrowband UVB phototherapy and psoralen plus UVA photochemotherapy. Br J Dermatol 2006; 154(5): 963-8. doi: 10.1111/j.1365-2133.2006.07171.xOtman SG, Edwards C, Pearse AD et al. Modulation of ultraviolet (UV) transmission by emollients: relevance to narrowband UVB phototherapy and psoralen plus UVA photochemotherapy. Br J Dermatol 2006; 154(5): 963-8. doi: 10.1111/j.1365-2133.2006.07171.xJung AG, Bertsch HP, Schoen MP et al. A rare case of a sclerodermoid chronic graft versus host disease. Successful treatment with extracorporeal photopheresis (ECP). Hautarzt 2010; 61(6): 514-517. doi: 10.1007/s00105-010-1924-9Jung AG, Bertsch HP, Schoen MP et al. A rare case of a sclerodermoid chronic graft versus host disease. Successful treatment with extracorporeal photopheresis (ECP). Hautarzt 2010; 61(6): 514-517. doi: 10.1007/s00105-010-1924-9Andreu-Ullrich H. Miscellaneous indications for extracorporeal photochemotherapy (ECP). Transfus Apher Sci 2014;50(3): 363-369. doi: 10.1016/j.transci.2014.04.007Andreu-Ullrich H. Miscellaneous indications for extracorporeal photochemotherapy (ECP). Transfus Apher Sci 2014;50(3): 363-369. doi: 10.1016/j.transci.2014.04.007Adamski J, Kinard T, Ipe T et al. Extracorporeal photopheresis for the treatment of autoimmune diseases. Transfus Apher Sci 2015; 52(2): 171-182. doi: 10.1016/j.transci.2015.02.005Adamski J, Kinard T, Ipe T et al. Extracorporeal photopheresis for the treatment of autoimmune diseases. Transfus Apher Sci 2015; 52(2): 171-182. doi: 10.1016/j.transci.2015.02.005Knobler R, Berlin G, Calzavara-Pinton P et al. Guidelines on the use of extracorporeal photopheresis. J Eur Acad Dermatol Venereol 2014; 28(1): 1-37. doi: 10.1111/jdv.12311Knobler R, Berlin G, Calzavara-Pinton P et al. Guidelines on the use of extracorporeal photopheresis. J Eur Acad Dermatol Venereol 2014; 28(1): 1-37. doi: 10.1111/jdv.12311Perotti C, Sniecinski I. A concise review on extracorporeal photochemotherapy: Where we began and where we are now and where are we going! Transfus Apher Sci 2015; 52(3): 360-368. doi: 10.1016/j.transci.2015.04.011Perotti C, Sniecinski I. A concise review on extracorporeal photochemotherapy: Where we began and where we are now and where are we going! Transfus Apher Sci 2015; 52(3): 360-368. doi: 10.1016/j.transci.2015.04.011Schwartz J, Winters JL, Padmanabhan A et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidencebased approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher 2013; 28(3): 145-284. doi: 10.1002/jca.21276Schwartz J, Winters JL, Padmanabhan A et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidencebased approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher 2013; 28(3): 145-284. doi: 10.1002/jca.21276Costanzo-Nordin MR, Hubbell EA, O’Sullivan EJ et al. Successful treatment of heart transplant rejection with photopheresis. Transplantation 1992; 53(4): 808-815. doi: 10.1097/00007890199204000-00021Costanzo-Nordin MR, Hubbell EA, O’Sullivan EJ et al. Successful treatment of heart transplant rejection with photopheresis. Transplantation 1992; 53(4): 808-815. doi: 10.1097/00007890199204000-00021Barten MJ, Dieterlen MT. Extracorporeal photopheresis after heart transplantation. Immunotherapy 2014;6(8):927-944. doi: 10.2217/imt.14.69Barten MJ, Dieterlen MT. Extracorporeal photopheresis after heart transplantation. Immunotherapy 2014;6(8):927-944. doi: 10.2217/imt.14.69Dieterlen MT, Bittner HB, Pierzchalski A et al. Immunological monitoring of extracorporeal photopheresis after heart transplantation. Clin Exp Immunol 2014; 176(1): 120-128. doi: 10.1111/cei.12254Dieterlen MT, Bittner HB, Pierzchalski A et al. Immunological monitoring of extracorporeal photopheresis after heart transplantation. Clin Exp Immunol 2014; 176(1): 120-128. doi: 10.1111/cei.12254Kapadia E, Wong E, Perez-Albuerne E et al. Extracorporeal photopheresis performed on the CELLEXR compared with the UVAR-XTSR instrument is more efficient and better tolerated in children with steroid-refractory graft-versus-host disease. Pediatr Blood Cancer 2015; 62(8): 1485-1488. doi: 10.1002/pbc.25487Kapadia E, Wong E, Perez-Albuerne E et al. Extracorporeal photopheresis performed on the CELLEXR compared with the UVAR-XTSR instrument is more efficient and better tolerated in children with steroid-refractory graft-versus-host disease. Pediatr Blood Cancer 2015; 62(8): 1485-1488. doi: 10.1002/pbc.25487Kitko CL, Levine JE. Extracorporeal photopheresis in prevention and treatment of acute GVHD. Transfus Apher Sci 2015; 52(2): 151-156. doi: 10.1016/j.transci.2015.02.001Kitko CL, Levine JE. Extracorporeal photopheresis in prevention and treatment of acute GVHD. Transfus Apher Sci 2015; 52(2): 151-156. doi: 10.1016/j.transci.2015.02.001Козлов АВ, Быкова ТА, Кулагина ИИ и др. Экстракорпоральный фотоферез в лечении реакции "трансплантат против хозяина". Гематол и трансфузиол 2014; 59(1): 47 [Kozlov AV, By`kova TA, Kulagina II i dr. E`kstrakorporal`ny`i` fotoferez v lechenii reaktcii "transplantat protiv hoziaina". Gematol i transfuziol 2014; 59(1): 47]Козлов АВ, Быкова ТА, Кулагина ИИ и др. Экстракорпоральный фотоферез в лечении реакции "трансплантат против хозяина". Гематол и трансфузиол 2014; 59(1): 47 [Kozlov AV, By`kova TA, Kulagina II i dr. E`kstrakorporal`ny`i` fotoferez v lechenii reaktcii "transplantat protiv hoziaina". Gematol i transfuziol 2014; 59(1): 47]Calore E, Marson P, Pillon М et al. Treatment of Acute Graft-versus-Host Disease in Childhood with Extracorporeal Photochemotherapy/Photopheresis: The Padova Experience. Biol Blood Marrow Transplant 2015; 21(11): 1963-1972. doi: 10.1016/j.bbmt.2015.07.007Calore E, Marson P, Pillon М et al. Treatment of Acute Graft-versus-Host Disease in Childhood with Extracorporeal Photochemotherapy/Photopheresis: The Padova Experience. Biol Blood Marrow Transplant 2015; 21(11): 1963-1972. doi: 10.1016/j.bbmt.2015.07.007Benden C, Speich R, Hofbauer GF et al. Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience. Transplantation 2008; 86(11): 1625-1627. doi: 10.1097/TP.0b013e31818bc024Benden C, Speich R, Hofbauer GF et al. Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience. Transplantation 2008; 86(11): 1625-1627. doi: 10.1097/TP.0b013e31818bc024Sato M, Waddell TK, Wagnetz U et al. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. J Heart Lung Transplant 2011; 30(7): 735-742. doi: 10.1016/j.healun.2011.01.712Sato M, Waddell TK, Wagnetz U et al. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. J Heart Lung Transplant 2011; 30(7): 735-742. doi: 10.1016/j.healun.2011.01.712Jaksch P, Scheed A, Keplinger M et al. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 2012; 31(9): 950-957. doi: 10.1016/j.healun.2012.05.002Jaksch P, Scheed A, Keplinger M et al. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 2012; 31(9): 950-957. doi: 10.1016/j.healun.2012.05.002Urbani L, Mazzoni A, Colombatto P et al. Potential applications of extracorporeal photopheresis in liver transplantation. Transplant Proc 2008; 40(4): 1175-1178. doi: 10.1016/j.transproceed.2008.03.071Urbani L, Mazzoni A, Colombatto P et al. Potential applications of extracorporeal photopheresis in liver transplantation. Transplant Proc 2008; 40(4): 1175-1178. doi: 10.1016/j.transproceed.2008.03.071Urbani L, Mazzoni A, Bianco I et al. The role of immunomodulation in ABO-incompatible adult liver transplant recipients. J Clin Apher 2008; 23(2): 55-62. doi: 10.1002/jca.20156Urbani L, Mazzoni A, Bianco I et al. The role of immunomodulation in ABO-incompatible adult liver transplant recipients. J Clin Apher 2008; 23(2): 55-62. doi: 10.1002/jca.20156Urbani L, Mazzoni A, Bindi L et al. A single-staggered dose of calcineurin inhibitor may be associated with neurotoxicity and nephrotoxicity immediately after liver transplantation. Clin Transplant 2009; 23(6): 853-860. doi: 10.1111/j.13990012.2009.00957.xUrbani L, Mazzoni A, Bindi L et al. A single-staggered dose of calcineurin inhibitor may be associated with neurotoxicity and nephrotoxicity immediately after liver transplantation. Clin Transplant 2009; 23(6): 853-860. doi: 10.1111/j.13990012.2009.00957.xBaron ED, Heeger PS, Hricik DE et al. Immunomodulatory effect of extracorporeal photopheresis after successful treatment of resistant renal allograft rejection. Photodermatol Photoimmunol Photomed 2001; 17(2): 79-82. doi: 10.1034/j.16000781.2001.017002079.xBaron ED, Heeger PS, Hricik DE et al. Immunomodulatory effect of extracorporeal photopheresis after successful treatment of resistant renal allograft rejection. Photodermatol Photoimmunol Photomed 2001; 17(2): 79-82. doi: 10.1034/j.16000781.2001.017002079.xKusztal M, Kłak R, Krajewska M et al. Application of extracorporeal photopheresis in kidney transplant recipients: technical considerations and procedure tolerance. Transplant Proc 2011; 43(8): 2941-2942. doi: 10.1016/j.transproceed.2011.08.034Kusztal M, Kłak R, Krajewska M et al. Application of extracorporeal photopheresis in kidney transplant recipients: technical considerations and procedure tolerance. Transplant Proc 2011; 43(8): 2941-2942. doi: 10.1016/j.transproceed.2011.08.034Федулкина ВА, Ватазин АВ, Кильдюшевский АВ и др. Трансляционная клеточная иммунотерапия при аллотрансплантации трупной почки у урологических больных. Альманах клин мед 2013; 28: 25-31 [Fedulkina V.A., Vatazin A.V., Kildyushevskii A.V. et al. Translational cellular immunotherapy for cadaveric kidney allograft in urological patients. Almanac of Clinical Medicine. 2013; 28: 25-31]Федулкина ВА, Ватазин АВ, Кильдюшевский АВ и др. Трансляционная клеточная иммунотерапия при аллотрансплантации трупной почки у урологических больных. Альманах клин мед 2013; 28: 25-31 [Fedulkina V.A., Vatazin A.V., Kildyushevskii A.V. et al. Translational cellular immunotherapy for cadaveric kidney allograft in urological patients. Almanac of Clinical Medicine. 2013; 28: 25-31]Кильдюшевский АВ, Федулкина ВА, Фомина ОА и др. Применение экстракорпоральной фотохимиотерапии при лимфомах кожи и трансплантации солидных органов. Альманах клин мед 2014; 30: 61-69 [Kildyushevsky AV, Fedulkina VA, Fomina OA et al. Application of extracorporeal photochemotherapy in skin lymphomas and transplantation of solid organs. Almanac of Clinical Medicine 2014; 30: 61-69]Кильдюшевский АВ, Федулкина ВА, Фомина ОА и др. Применение экстракорпоральной фотохимиотерапии при лимфомах кожи и трансплантации солидных органов. Альманах клин мед 2014; 30: 61-69 [Kildyushevsky AV, Fedulkina VA, Fomina OA et al. Application of extracorporeal photochemotherapy in skin lymphomas and transplantation of solid organs. Almanac of Clinical Medicine 2014; 30: 61-69]Schmid D, Grabmer C, Streif D et al. T-cell death, phosphatidylserine exposure and reduced proliferation rate to validate extracorporeal photochemotherapy. Vox Sang 2015; 108(1): 8288. doi: 10.1111/vox.12200Schmid D, Grabmer C, Streif D et al. T-cell death, phosphatidylserine exposure and reduced proliferation rate to validate extracorporeal photochemotherapy. Vox Sang 2015; 108(1): 8288. doi: 10.1111/vox.12200Holtick U, Wang XN, Marshall SR et al. In vitro PUVA treatment preferentially induces apoptosis in alloactivated T cells. Transplantation 2012; 94(5): 31-34. doi: 10.1097/TP.0b013e31825f4454Holtick U, Wang XN, Marshall SR et al. In vitro PUVA treatment preferentially induces apoptosis in alloactivated T cells. Transplantation 2012; 94(5): 31-34. doi: 10.1097/TP.0b013e31825f4454Heshmati F. Updating ECP action mechanisms. Transfus Apher Sci 2014; 50(3): 330-339. doi: 10.1016/j.transci. 2014.04.003Heshmati F. Updating ECP action mechanisms. Transfus Apher Sci 2014; 50(3): 330-339. doi: 10.1016/j.transci. 2014.04.003Hannani D, Merlin E, Gabert F et al. Photochemotherapy induces a faster apoptosis of all reactive activated T cells than of nonalloreactive resting T cells in GvHD. Transplantation 2010; 90(11): 1232–1238. doi: 10.1097/TP.0b013e3181fa4eb6Hannani D, Merlin E, Gabert F et al. Photochemotherapy induces a faster apoptosis of all reactive activated T cells than of nonalloreactive resting T cells in GvHD. Transplantation 2010; 90(11): 1232–1238. doi: 10.1097/TP.0b013e3181fa4eb6Yoo EK, Rook AH, Elenitsas R et al. Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol 1996; 107(2): 235-242. doi: 10.1111/1523-1747.ep12329711Yoo EK, Rook AH, Elenitsas R et al. Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol 1996; 107(2): 235-242. doi: 10.1111/1523-1747.ep12329711Setterblad N, Garban F, Weigl R et al. Extracorporeal photophoresis increases sensitivity of monocytes from patients with graft-versus-host disease to HLA-DR-mediated cell death. Transfusion 2007; 48(1): 169-177. doi: 10.1111/j.15372995.2007.01502.xSetterblad N, Garban F, Weigl R et al. Extracorporeal photophoresis increases sensitivity of monocytes from patients with graft-versus-host disease to HLA-DR-mediated cell death. Transfusion 2007; 48(1): 169-177. doi: 10.1111/j.15372995.2007.01502.xUsharauli D. Dendritic cells and the immunity/tolerance decision. Med Hypotheses 2005; 64(1): 112-113. doi: 10.1016/j.mehy.2004.02.061Usharauli D. Dendritic cells and the immunity/tolerance decision. Med Hypotheses 2005; 64(1): 112-113. doi: 10.1016/j.mehy.2004.02.061Morelli AE. The immune regulatory effect of apoptotic cells and exosomes on dendritic cells: its impact on transplantation. Am J Transplant 2006; 6(2): 254-261. doi: 10.1111/j.16006143.2005.01197.xMorelli AE. The immune regulatory effect of apoptotic cells and exosomes on dendritic cells: its impact on transplantation. Am J Transplant 2006; 6(2): 254-261. doi: 10.1111/j.16006143.2005.01197.xBittencourt MC, Perruche S, Contassot E et al. Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers. Blood 2001; 98(1): 224-230. doi: 10.1182/blood.V98.1.224Bittencourt MC, Perruche S, Contassot E et al. Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers. Blood 2001; 98(1): 224-230. doi: 10.1182/blood.V98.1.224Kleinclauss F, Perruche S, Masson E et al. Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion. Cell Death Differ 2005; 13(1): 41-52. doi:10.1038/sj.cdd.4401699Kleinclauss F, Perruche S, Masson E et al. Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion. Cell Death Differ 2005; 13(1): 41-52. doi:10.1038/sj.cdd.4401699Morelli AE, Larregina AT, Shufesky WJ et al. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 2003; 101(2): 611-620. doi: 10.1182/blood-2002-06-1769Morelli AE, Larregina AT, Shufesky WJ et al. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 2003; 101(2): 611-620. doi: 10.1182/blood-2002-06-1769Hannani D, Merlin E, Gabert F et al. Photochemotherapy induces a faster apoptosis of alloreactive activated T cells than of nonalloreactive resting T cells in graft versus host disease. Transplantation 2010; 90(11): 1232-1238. doi: 10.1097/TP.0b013e3181fa4eb6Hannani D, Merlin E, Gabert F et al. Photochemotherapy induces a faster apoptosis of alloreactive activated T cells than of nonalloreactive resting T cells in graft versus host disease. Transplantation 2010; 90(11): 1232-1238. doi: 10.1097/TP.0b013e3181fa4eb6Peritt D. Potential mechanisms of action of photopheresis in hematopoietic stem cell transplantation. Biol Blood Marrow Transplantation 2006; 12: 7-12. doi: 10.1016/j.bbmt.2005.11.005Peritt D. Potential mechanisms of action of photopheresis in hematopoietic stem cell transplantation. Biol Blood Marrow Transplantation 2006; 12: 7-12. doi: 10.1016/j.bbmt.2005.11.005Martin PJ. Biology of chronic graft-versus-host disease: implications for a future therapeutic approach. Keio J Med 2008; 57(4): 177-183. doi: 10.2302/kjm.57.177Martin PJ. Biology of chronic graft-versus-host disease: implications for a future therapeutic approach. Keio J Med 2008; 57(4): 177-183. doi: 10.2302/kjm.57.177Iyoda T, Shimoyama S, Liu K et al. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med 2002; 195(10): 1289-1302. doi: 10.1084/jem.20020161Iyoda T, Shimoyama S, Liu K et al. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med 2002; 195(10): 1289-1302. doi: 10.1084/jem.20020161Gorgun G, Miller KB, Foss FM. Immunologic mechanisms of extracorporeal photochemotherapy in chronic graftversushost disease. Blood 2002; 100(3): 941-947. doi: 10.1182/ blood-2002-01-0068Gorgun G, Miller KB, Foss FM. Immunologic mechanisms of extracorporeal photochemotherapy in chronic graftversushost disease. Blood 2002; 100(3): 941-947. doi: 10.1182/ blood-2002-01-0068Baron ED, Heeger PS, Hricik DE et al. Immunomodulatory effect of extracorporeal photopheresis after successful treatment of resistant renal allograft rejection. Photodermatol Photoimmunol Photomed 2001; 17(2): 79-82. doi: 10.1034/j.16000781.2001.017002079.xBaron ED, Heeger PS, Hricik DE et al. Immunomodulatory effect of extracorporeal photopheresis after successful treatment of resistant renal allograft rejection. Photodermatol Photoimmunol Photomed 2001; 17(2): 79-82. doi: 10.1034/j.16000781.2001.017002079.xInaba K, Turley S, Yamaide F et al. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med 1998; 188(11): 2163-2173. doi: 10.1084/jem.188.11.2163Inaba K, Turley S, Yamaide F et al. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med 1998; 188(11): 2163-2173. doi: 10.1084/jem.188.11.2163Dhodapkar MV, Steinman RM. Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood 2002; 100(1): 174-177. doi: 10.1182/blood.V100.1.174Dhodapkar MV, Steinman RM. Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood 2002; 100(1): 174-177. doi: 10.1182/blood.V100.1.174Spisek R, Gasova Z, Bartunkova J. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease. Transfusion 2006; 46(1): 55-65. doi: 10.1111/j.15372995.2005.00670.xSpisek R, Gasova Z, Bartunkova J. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease. Transfusion 2006; 46(1): 55-65. doi: 10.1111/j.15372995.2005.00670.xVogel I, Kasran A, Cremer J et al. CD28/CTLA-4/B7 costimulatory pathway blockade affects regulatory T-cell function in autoimmunity. Eur J Immunol 2015; 45(6): 1832-1841. doi: 10.1002/eji.201445190Vogel I, Kasran A, Cremer J et al. CD28/CTLA-4/B7 costimulatory pathway blockade affects regulatory T-cell function in autoimmunity. Eur J Immunol 2015; 45(6): 1832-1841. doi: 10.1002/eji.201445190Coutinho A, Caramalho I, Seixas E et al. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection. Current Topics in Microbiology and Immunology 2005; 293: 43-71. doi: 10.1007/3-540-27702-1_3Coutinho A, Caramalho I, Seixas E et al. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection. Current Topics in Microbiology and Immunology 2005; 293: 43-71. doi: 10.1007/3-540-27702-1_3Hu G, Liu Z, Zheng C et al. Antigen-non-specific regulation centered on CD25+Foxp3+ Treg cells. Cell Mol Immunol 2010; 7(6): 414-418. doi: 10.1038/cmi.2010.39Hu G, Liu Z, Zheng C et al. Antigen-non-specific regulation centered on CD25+Foxp3+ Treg cells. Cell Mol Immunol 2010; 7(6): 414-418. doi: 10.1038/cmi.2010.39Viglietta V, Baecher-Allan C, Weiner HL et al. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199(7): 971-979. doi: 10.1084/jem.20031579Viglietta V, Baecher-Allan C, Weiner HL et al. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199(7): 971-979. doi: 10.1084/jem.20031579Yang XF. Factors regulating apoptosis and homeostasis of CD4+ CD25(high) FOXP3+ regulatory T cells are new therapeutic targets. Front Biosci 2008; 13: 1472-1499. doi: 10.2741/2775Yang XF. Factors regulating apoptosis and homeostasis of CD4+ CD25(high) FOXP3+ regulatory T cells are new therapeutic targets. Front Biosci 2008; 13: 1472-1499. doi: 10.2741/2775Dhaeze T, Peelen E, Hombrouck A et al. Circulating Follicular Regulatory T Cells Are Defective in Multiple Sclerosis. J Immunol 2015; 195(3): 832-840. doi: 10.4049/jimmunol.1500759Dhaeze T, Peelen E, Hombrouck A et al. Circulating Follicular Regulatory T Cells Are Defective in Multiple Sclerosis. J Immunol 2015; 195(3): 832-840. doi: 10.4049/jimmunol.1500759Hara M, Kingsley CI, Niimi M et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001; 166(6): 3789-3796. doi: 10.4049/jimmunol.166.6.3789Hara M, Kingsley CI, Niimi M et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001; 166(6): 3789-3796. doi: 10.4049/jimmunol.166.6.3789Cohen JL, Trenado A, Vasey D et al. CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versushost disease. J Exp Med 2002; 196(3): 401-406. doi: 10.1084/jem.20020090Cohen JL, Trenado A, Vasey D et al. CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versushost disease. J Exp Med 2002; 196(3): 401-406. doi: 10.1084/jem.20020090Biagi E, Di Biaso I, Leoni V et al. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. Transplantation 2007; 84(1): 31-39Biagi E, Di Biaso I, Leoni V et al. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. Transplantation 2007; 84(1): 31-39Meloni F, Cascina A, Miserere S et al. Peripheral CD4(+) CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients. Transplant Proc 2007; 39(1): 213-217. doi: 10.1016/j.transproceed.2006.10.227Meloni F, Cascina A, Miserere S et al. Peripheral CD4(+) CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients. Transplant Proc 2007; 39(1): 213-217. doi: 10.1016/j.transproceed.2006.10.227

The authors declare that there are no conflicts of interest present.